340B A Critical Program for Health Centers
The 340B Drug Pricing Program is an essential source of support for Community Health Centers, allowing them to stretch increasingly scarce federal resources and reinvest in patient care. The program allows health centers to purchase outpatient drugs at significantly reduced costs. Health centers pass the savings on to their patients through reduced drug prices and invest additional savings to expand access and improve health outcomes.
Health center patients include people living with HIV, people who have lost their jobs and health insurance in the economic decline, or even essential workers who test positive for COVID-19 but do not require hospitalization. The cost of medicines can easily push them further into poverty, disease, even death.
Current Threats to the 340B Program
NACHC is concerned about ongoing actions by drug companies that threaten patient access to critical medicines available through the federal 340B Program. These attacks have diverted savings away from patient care and into corporate pockets, ultimately tying the hands of health center doctors and other care providers in the midst of the COVID-19 pandemic.
ASAP 340B: Alliance to Save 340B
NACHC, alongside PhRMA, formed the Alliance to Save America’s 340B Program (ASAP 340B) to work towards a congressional solution to clarify parts of the 340B program. This partnership, which also includes patient, provider, and consumer advocates, aims to ensure the 340B program supports true safety-net providers and the communities they serve. NACHC is excited to work collaboratively to find solutions for all stakeholders in the 340B program.
Latest from NACHC about 340B
Press Release: NACHC Leads Overwhelming Response from Health Centers to Senate 340B Request for Information (July 31, 2023)
Statement: New Alliance of Health Care Leaders Calls on Congress to Save America’s 340B Program (March 2023)
Advocacy Campaign: Visit our grassroots advocacy website to get involved in our campaign to #Protect340B.